Get the answers you've been looking for with the help of IDNLearn.com's expert community. Get accurate and detailed answers to your questions from our dedicated community members who are always ready to help.
Sagot :
Final answer:
The drug combination relieves hot flashes and prevents osteoporosis but does not reduce the risk of ovarian cancer.
Explanation:
Reduces the risk of ovarian cancer: The combination of transdermal conjugated estrogen and medroxyprogesterone does not reduce the risk of ovarian cancer.
Relieves hot flashes: This drug combination helps in relieving hot flashes, a common symptom of menopause.
Prevents osteoporosis: It aids in preventing osteoporosis by reducing the loss of calcium from bones.
Learn more about Menopausal hormone therapy here:
https://brainly.com/question/32155538
We are delighted to have you as part of our community. Keep asking, answering, and sharing your insights. Together, we can create a valuable knowledge resource. IDNLearn.com has the answers you need. Thank you for visiting, and we look forward to helping you again soon.